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A recombinant herpes simplex virus type 1 expressing murine interferon- (IFN-) was constructed (HSV-IFN-) to study
the effect of IFN- expression on HSV-1 infection of mice. HSV-IFN- was created by inserting the gene for murine IFN-
under the control of the latency-associated transcript (LAT) promoter in a LAT-negative recombinant virus. ELISA analysis
confirmed that the recombinant virus expressed high levels of IFN- in tissue culture. The recombinant HSV-IFN- had
reduced virulence compared with the wild-type and LAT parental strains as judged by death following ocular and ip
infections in BALB/c mice. Replication of HSV-IFN- was wild type in tissue culture and mouse eyes. In addition, peak
HSV-IFN- titers in mouse trigeminal ganglia (TG) and brain were similar for all viruses, although HSV-IFN- appeared in the
TG and brains of ocularly infected mice earlier than either parental virus. Following stimulation with UV-inactivated virus,
lymphocytes from HSV-IFN--infected mice appeared to produce a steady level of interleukin-2 (IL-2) and IFN- throughout
the first week of infection, while the IL-2 and IFN- levels in lymphocytes from wild-type and the LAT-negative parental virus,
dLAT2903, varied over time. Also in contrast to lymphocytes from wild-type and dLAT2903-infected mice, lymphocytes from
HSV-IFN--infected mice produced no detectable IL-4. Following stimulation with recombinant IFN- (rIFN-), lymphocytes
from HSV-IFN--infected mice produced higher levels of IFN-, as compared to lymphocytes from control virus-infected mice.
Finally, CTL and cell proliferation induced by HSV-IFN- were similar to those of both parental viruses. Thus, this report
demonstrates that (i) HSV-IFN- had reduced neurovirulence, despite having enhanced replication in the TG of infected mice;en in wINTRODUCTION
IFN- is a cytokine secreted by activated CD4 T helper
1 (TH1) cells, natural killer (NK) cells, and CD8
 cytotoxic
(Tc1) suppressor cells (Biron, 1997; Mosmann and Sad,
1996; Sad et al., 1995). The IFN- antiviral defense mecha-
nism that occurs very early during the course of infection
interferes both with the early steps of virus invasion and
replication (Gaines et al., 1987; Karupiah et al., 1993a; Mul-
ler et al., 1994; Samuel, 1991), and with the control of
persistent infection (Iwashiro et al., 2001; Tishon et al.,
1995). IFN- has immunomodulatory effects on CD4 TH2,
CD8 Tc2, macrophages, NK, and B cells (Trinchieri, 1989;
van den Broek et al., 1995). In vivo depletion studies have
shown that IFN- is critical for the antiviral activities of
macrophages (Feduchi and Carrasco, 1991; Karupiah et al.,
1993b). IFN- knockout (KO) mice developed an effective
CTL response that cleared virus after an acute infection but
not after a persistent infection (Tishon et al., 1995).
Previous studies have shown that IFN- is an essen-
tial immune factor for clearance of HSV from cutaneous
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144sites of infection (Smith et al., 1994; Yu et al., 1996), and
from the nervous system (Cantin et al., 1995). Mice de-
pleted of IFN- using IFN- antibodies were more sus-
ceptible to HSV infection and death than control mice
(Smith et al., 1994). Similarly, KO mice with a disrupted
IFN- (Yu et al., 1996) or IFN- receptor gene (Cantin et
al., 1999) were more susceptible to infection than their
normal counterparts. These studies suggest that IFN-
plays an important role in limiting HSV replication at the
acute stage and improves survival of challenged mice
(Cantin et al., 1995; Yu et al., 1996). Similar results have
been reported for the importance of IFN- in the control
of primary HSV infection in humans (Burchett et al., 1992;
Yamamoto et al., 1993). In contrast, other studies have
suggested that IFN- is not essential for the clearance of
virus (Milligan and Bernstein, 1997) or for protection
against HSV-1 challenge (Bouley et al., 1995; Ghiasi et
al., 2000).
The above studies using knockout mice, transgenic
mice, and in vivo depletion of IFN- have suggested that
IFN- may (Cantin et al., 1995; Geiger et al., 1994b; Smith
et al., 1994; Yu et al., 1996) or may not (Bouley et al., 1995;
Ghiasi et al., 2000; Milligan and Bernstein, 1997) play an(ii) HSV-IFN- did not enhance CTL activity above that se
pattern of cytokine response. © 2002 Elsevier Science (USA)
To whom reprint requests should be addressed. Fax: (310) 423-
0225. E-mail: ghiasih@cshs.org.
doi:10.1006/viro.2002.1609
0042-6822/02 $35.00ild-type infected mice; and (iii) HSV-IFN- induced a TH1
important role in protection against HSV-1 infection. In
this study, we sought to examine the effect of IFN- in
protection against HSV-1 infection by constructing a re-
combinant HSV-1 virus expressing high levels of IFN-
under the strong LAT promoter. We compared the course
of virus replication and spread and functional character-
istics of T-cell responses and their cytokine production
milieu following infection with HSV-IFN- or its parental
virus. The results in this report suggest that IFN--ex-
pressing virus was less pathogenic than parental virus
and that IFN--expressing virus suppress IL-4 produc-
tion. These findings support the hypothesis that IFN-
plays a role in protection against HSV-1 infection, per-
haps at least partially by producing IFN- for a longer
time.
RESULTS
Structure of HSV-IFN-
HSV-1 strain McKrae was used as the original parental
virus. The genomic structure of McKrae is shown sche-
matically in Fig. 1A. The HSV-1 genome contains a
unique long region (UL) and a unique short region (Us)
(solid lines), each flanked by inverted repeats {open
rectangles; terminal and internal repeats long (TRL and
IRL) and terminal and internal repeats short (TRS and
IRS)}. The location of the LAT promoter TATA box is
indicated as TATA. The LAT transcription start site is 28
nt downstream of the TATA box (Zwaagstra et al., 1990).
The LAT null mutant dLAT2903 (Perng et al., 1994) is
shown schematically in Fig. 1B. dLAT2903 contains a
1.8-kb deletion in both copies of the LAT gene (one in
each long repeat). This deletion (indicated by XX) con-
sists of 0.2 kb of the LAT promoter and the portion of the
LAT gene encoding the first 1.6 kb of the 8.3-kb primary
LAT transcript. It extends to LAT nt 1667. dLAT2903 is
identical to McKrae for replication in tissue culture, eyes,
TG, and brain, and for survival following ocular challenge
of rabbit (Perng et al., 1994). HSV-IFN- was derived from
dLAT2903 by the insertion of the IFN- gene under con-
trol of the LAT promoter (Fig. 1C) as described under
Materials and Methods. In the final recombinant virus the
IFN- gene has been inserted into the LAT gene in place
of LAT nucleotides 76 to 1667. As confirmed by restriction
enzyme analysis and partial sequencing, the IFN- gene
insert has a noncoding region of 36 nucleotides in front
of the first ATG. This is followed by the complete 534
nucleotide IFN- coding region and 201 noncoding nu-
cleotides. The IFN- poly(A) signal is present at the 3
end of the insert. There are two complete copies of the
IFN- gene, one in each viral long repeat.
Expression of IFN- in tissue culture
Confluent monolayers of RS cells and L929 cells were
infected at a multiplicity of 0.1 PFU/cell for up to 96 h with
HSV-IFN-, dLAT2903, or McKrae. Conditioned medium
was collected at various times and assayed by ELISA for
the presence of IFN- protein as described under Mate-
rials and Methods. As expected, no IFN- was detected
in the supernatants of RS or L929 cells infected with
dLAT2903 or McKrae at any time postinfection (not
shown). In contrast, significant IFN- was detected in the
supernatants of RS and L929 cells infected with HSV-
IFN- (Fig. 2). Preincubation of conditioned media with a
polyclonal anti-IFN- antibody (Peprotech Inc) prior to
FIG. 1. Construction and structure of the HSV-IFN- recombinant virus. (A) The top of the schematic shows the HSV-1 McKrae genome in the
prototypic orientation. The rectangles labeled long terminal repeat (TRL) and long inverted repeat (IRL) represent the terminal and internal (or inverted)
long repeats, while the rectangles labeled short terminal repeat (TRS) and short inverted repeat (IRS) represent the terminal and internal (or inverted)
short repeats. Unique long (UL) and unique short (US) represent the long and short unique regions, respectively. The expanded presentation of part
of the internal long and short repeats indicates the location and direction of LAT transcription. The ICP0 mRNA is shown for reference. The solid
rectangle represents the very stable 2-kb LAT. The start of LAT transcription is indicated by the arrow at 1. (B) dLAT2903 has a deletion from LAT
nucleotides 161 to 1667 in both copies of LAT and makes no LAT RNA. (C) HSV-IFN- was constructed from dLAT2903 by homologous
recombination between dLAT2903 DNA and a plasmid containing the complete LAT promoter and the entire structural IFN- gene (including its 3
poly(A) signal) as described under Materials and Methods.
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the ELISA assay using a mAb (BD, San Diego, CA)
resulted in no detection of IFN-, strongly supporting the
specificity of the assay (not shown). These results show
that HSV-IFN- expresses IFN- that is secreted into the
medium.
Replication of HSV-IFN- in tissue culture
To determine whether expression of IFN- by HSV-
IFN- altered replication in tissue culture, RS cells were
infected with 0.01 PFU/cell of HSV-IFN-, dLAT2903, or
wt McKrae. The monolayers were freeze-thawed at the
indicated times, and virus yield was determined as de-
scribed under Materials and Methods. Replication of
HSV-IFN- appeared similar to that of dLAT2903 and wt
McKrae (Fig. 3A; P  0.05 at all time points). This
suggests that the recombinantly expressed IFN- had no
direct effect on virus replication in tissue culture. It also
strongly suggests that the recombinant HSV-IFN- does
not contain any unexpected mutations that effect virus
replication in tissue culture.
Replication of HSV-IFN- in mouse tears
BALB/c (H-2d) mice, which are highly sensitive to
HSV-1 infection, were ocularly infected with 2  105
PFU/eye of HSV-IFN-, dLAT2903, or wt McKrae as de-
scribed under Materials and Methods. From Day 1 to
Day 9 postinfection, tear films were collected from 10
eyes per group and assayed for the amount of virus by
plaque assays on RS cells (Fig. 3B). Replication of all
three viruses was similar. Replication of HSV-IFN- was
also examined in C57BL/6 (H-2b) mice which have a
different major histocompatibility (MHC) background
than BALB/c mice. The C57BL/6 mice are more resistant
to HSV-1 infection and were therefore infected with 2 
106 PFU/eye of each virus. As above, the replication of all
three viruses was similar (Fig. 3C). Thus, IFN- ex-
pressed by HSV-IFN- appeared to have no effect on
virus replication in the eyes of either H-2b or H-2d mice.
Replication of HSV-IFN- in whole eyes, TGs, and
brain of mice
BALB/c mice were ocularly infected with 2  105
PFU/eye of HSV-IFN- or dLAT2903 and euthanized 3, 5,
or 7 days later. In experiment 1, 3 mice were used per
time point per virus. In Experiment 2, 4 mice were used
per time point. The data from the two experiments were
combined and are shown in Fig. 4. As in tears, there was
no difference in viral replication as determined by the
amount of virus found in ground up whole eyes between
HSV-IFN- and dLAT2903 (Fig. 4A). In contrast, com-
pared to dLAT2903, HSV-IFN--infected mice had more
virus in their TGs and brains on Day 3 postinfection (Figs.
4B and C). On Days 5 and 7 postinfection, the amount of
HSV-IFN- in TG and brains was similar to dLAT2903.
Thus, ocular infection of mice with HSV-IFN- appeared
to result in normal replication in eyes and an earlier
appearance (or slightly increased replication) in the TG
and brain.
Virulence of HSV-IFN- in BALB/c mice
Groups of 5 to 25 BALB/c mice were infected ocularly
in both eyes or ip with 10-fold serial dilutions of virus
ranging from 4  102 to 4  107 PFU/mouse (2  102 to
2  107 PFU/eye). The 50% lethal dose (LD50) was deter-
mined for each group (Table 1). Following ocular chal-
lenge the LD50 for HSV-IFN- (approximately 5000 PFU)
was approximately 10-fold greater than the LD50s for
dLAT2903 or wt McKrae, and marker-rescued HSV-
IFN-R (approximately 300 to 600 PFU). The marker-
rescued virus HSV-IFN-R was generated by cotransfec-
tion and homologous recombination of infectious HSV-
IFN- DNA with the original pLAT plasmid as described
under Materials and Methods and contains the original
LAT deletion in place of the recombinantly inserted IFN-
gene. The HSV-IFN- LD50 following ip challenge (ap-
proximately 160,000 PFU) was also about 10-fold higher
than those for dLAT2903 and HSV-IFN-R (approximately
4000 to 13,000). Thus, HSV-IFN- appeared to be less
virulent than its parental viruses or marker-rescued virus
as judged by the ability to kill BALB/c mice following both
ocular and ip challenge. This suggests that the reduced
mortality in HSV-IFN--infected mice was due to the
presence of IFN- rather than a defect in the recombi-
nant virus.
LD50 studies were also performed in C57BL/6 mice.
However, because of the much more resistant nature of
these mice to HSV-1 infection, even at the highest chal-
lenge dose, neither ocular nor ip challenge killed all of
the mice. It was therefore not possible to calculate LD50s
in C57BL/6 mice.
FIG. 2. Kinetics of expression of IFN- by HSV-IFN-. Subconfluent
monolayers of RS or L929 cells were infected with 0.1 PFU per cell of
HSV-IFN-, as described under Materials and Methods. Supernatant
was harvested at the indicated times postinfection and the amount of
expressed IFN- was determined by ELISA as described under Mate-
rials and Methods.
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Effect of IFN- on virus-specific lymphokine
production
IFN- is an indicator of a TH1 response and blocks TH2
responses. To determine if compared to wild-type HSV-1
infection HSV-IFN- induces an enhanced TH1 response
in infected mice, BALB/c mice were mock-infected or
ocularly challenged with 2  105 PFU/eye of HSV-IFN-,
dLAT2903, or McKrae. Splenocytes were isolated from
the spleens of infected mice on Days 3, 5, and 7 postin-
fection. The splenocytes were stimulated in vitro with 5
PFU/cell of UV-inactivated McKrae. Seventy-two hours
after in vitro stimulation, cell culture supernatants were
harvested for analysis of IL-2, IL-4, and IFN- production.
Overall, HSV-IFN- infection led to the production of
IL-2 and IFN-, but not IL-4, by splenocytes stimulated in
vitro. Splenocytes from mock-infected control mice and
splenocytes that were not stimulated in vitro did not
produce detectable levels of any of these cytokines (not
shown). IL-2 responses appeared similar with all three
viruses (Fig. 5A). IL-4 levels appeared similar for wild-
type and dLAT2903-infected mice (Fig. 5B). In contrast,
spleen cells from HSV-IFN--infected mice did not ap-
pear to produce any IL-4 (Fig. 5B).
IFN- production in splenocytes from HSV-IFN--in-
fected mice appeared similar on all days (Fig. 5C). In
contrast, IFN- production was low in splenocytes from
wild-type and dLAT2903-infected mice on Day 3 and then
increased. Thus, the kinetics of IFN- production in re-
sponse to stimulation with UV inactivated virus appeared
to be different for HSV-IFN--infected mice compared to
wild-type or dLAT2903 infected mice.
CTL activity
Spleen cells collected 3, 5, and 7 days postinfection
with HSV-IFN-, dLAT2903, or McKrae were tested for
CTL activity as described under Materials and Methods.
No significant differences were seen for any of the in-
fected groups on Days 3, 5, or 7 after ocular challenge
(Fig. 6A). All three infected groups had significantly more
CTL activity than mock-infected mice. These results sug-
gest that HSV-IFN- infection did not result in altered
FIG. 3. Replication of HSV-IFN- in vitro and in vivo. (A) HSV-IFN-
replication in tissue culture. Subconfluent RS cell monolayers were
infected in triplicate with 0.01 PFU per cell of HSV-IFN-, McKrae, or
dLAT2903 as described under Materials and Methods. Total virus was
harvested at the indicated times postinfection by two cycles of freeze-
thawing. The amount of virus at each time for each virus was deter-
mined by standard plaque assays on RS cells. Each point represents
the mean of the titers from 6 assays  SEM. (B) Replication of HSV-
IFN- in tears of BALB/c mice. BALB/c mice were ocularly infected with
2  105 PFU per eye of HSV-IFN-, McKrae, or dLAT2903. Tear films
were collected on the days indicated, and virus titers were determined
by standard plaque assays. Each point represents the mean of the
titers from 10 eyes  SEM. (C) Replication of HSV-IFN- in tears of
C57BL/6 mice. C57BL/6 mice were ocularly infected with 2  105 PFU
per eye of HSV-IFN-, McKrae, or dLAT2903. Virus titers were deter-
mined as above. Each point represents the mean of the titers from 10
eyes  SEM.
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CTL activity compared to infection with dLAT2903 or
McKrae. Interestingly, the CTL activity for all three in-
fected groups appeared highest on Day 3 and declined
through Day 7 postinfection. This may be due to the high
virulence levels of these McKrae based mutants in
BALB/c mice.
Lymphocyte proliferation
Induction of a lymphocyte proliferation response was
determined as described under Materials and Methods,
using spleen cells from the same mice used above for
measuring CTL. In the absence of in vitro priming none of
the groups showed any increase in incorporation of
[3H]thymidine compared to the mock-infected control
group (not shown). After stimulation of the spleen cells
with UV-inactivated HSV-1, significant lymphocyte prolif-
eration was detected in all three groups (P  0.01
versus mock, Student t test) (Fig. 6B). The pattern and
amount of lymphocyte proliferation were similar for all
three infected groups. As seen above for CTL activity,
lymphocyte proliferation declined from Day 3 to Day 7
postchallenge.
In vitro stimulation of lymphocytes with soluble rIFN-
Spleen cells from mice that were challenged as above
were stimulated in vitro with 5 g of soluble rIFN- per
2  105 spleen cells for 72 h and IFN- production was
measured as above on Days 3, 5, and 7 postinfection
(Fig. 7). Similar to stimulation with UV-inactivated wild-
type virus, stimulation with rIFN- produced similar lev-
els of IFN- at all times examined. However, rIFN-
stimulation resulted in approximately 4-fold more rIFN-
production (approximately 4300 pg/ml) than stimulation
with UV-inactivated virus (approximately 1000 pg/ml; Fig.
5C above). IFN- production was higher in splenocytes
from HSV-IFN--infected mice than in cells from
dLAT2903, McKrae, or uninfected mice on all days. On
Day 3 postinfection, stimulation with rIFN- resulted in
similar levels of IFN- production by splenocytes from
dLAT2903, McKrae, and mock-infected mice (Fig. 7). By
Day 5 postinfection, splenocytes from dLAT2903-infected
mice appeared to have lost their ability to respond to
stimulation by rIFN-, while splenocytes from wild-type
McKrae-infected mice appeared to have lost their ability
to respond to stimulation by rIFN- by Day 7 postinfec-
tion. In contrast, splenocytes from mock-infected mice
continued to respond to rIFN- stimulation throughout
the entire time period examined.
DISCUSSION
IFN- has been reported to have a number of biolog-
ical functions including expression of MHC antigen and
activation of macrophages, NK cells, and B cells (Biron,
1997; Li et al., 1997; Mosmann and Sad, 1996; Sad et al.,
FIG. 4. Viral titers in mouse whole eyes, TGs, and brain. BALB/c
mice were ocularly infected with 2  105 PFU per eye of HSV-IFN-,
McKrae, or dLAT2903 as described under Materials and Methods.
Mice were euthanized on the indicated days. Eyes (A), TGs (B), and
brains (C) were removed and homogenized, and virus titers were
determined as described under Materials and Methods. Experi-
ments were repeated twice. Each point represents the mean of the
titers from 14 eyes, 14 TGs, or 7 brains.
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1995; Trinchieri, 1989; van den Broek et al., 1995). In
addition to its protective role, IFN- is considered to be
a pleiotropic cytokine exhibiting inhibitory activities such
as interference with viral replication, inhibition of bone
marrow cell proliferation, inhibition of B cell proliferation
and antibody secretion, and inhibition of TH2 but not TH1
activity (Coffman and Carty, 1986; Gajewski et al., 1988;
Rabin et al., 1986; Spitalny and Havell, 1984; Vogel et al.,
1982). We have constructed and reported here on HSV-
IFN-, a recombinant HSV-1 that expresses murine IFN-
under control of the powerful viral LAT promoter. The
immediate parental virus for HSV-IFN- is the LAT-null
recombinant dLAT2903. The parental virus for dLAT2903
is wild-type McKrae. The marker-rescued virus HSV-
IFN-R has the IFN- gene removed and replaced by the
original LAT gene. This set of 3 viruses differs only at the
LAT locus. Wild-type McKrae express LAT and no IFN-,
dLAT2903 expresses neither LAT nor IFN-, and HSV-
IFN- expresses IFN- and no LAT. Together, these vi-
ruses form a useful tool to study the effect of exogenous
IFN- production on HSV-1 infection. Overall, our results
suggest that the IFN- produced by HSV-IFN- modu-
lates the immune response and provides a modest
amount of protection against HSV-1 virulence (with viru-
lence defined as reduced survival) in BALB/c mice.
In both rabbit skin (RS) and mouse (L929) cells in-
fected with HSV-IFN-, IFN- was secreted into the me-
dia. IFN- expression appeared to be higher in HSV-IFN-
-infected L929 cells than in HSV-IFN--infected RS
cells. This may be related to the fact that in general RS
cells support HSV-1 replication better than L929 cells.
Replication of HSV-IFN- in tissue culture was similar to
that of the parental strains. Consistent with these results,
rIFN- did not decrease wt McKrae virus replication in
either of these cell lines (not shown).
As judged by the amount of infectious virus in tears,
HSV-IFN- replicated to similar titers as the parental
viruses in the eyes of both BALB/c and C57BL/6 mice.
Thus, the presence of IFN- in the tears of HSV-IFN--
infected mice did not appear to have enhanced clear-
ance of virus over that seen for the parental viruses.
Other groups using in vivo depletion of IFN- have
shown that the absence of IFN- slowed HSV clearance
from the site of infection (Milligan and Bernstein, 1997;
Smith et al., 1994). Similarly we, and others, have shown
that IFN-/ mice are less efficient in clearance of virus
than their parental control mice (Bouley et al., 1995;
Ghiasi et al., 2000). Thus, these results suggest that
while the absence of IFN- decreased virus replication
at the site of infection, the addition of exogenous IFN-
introduced by HSV-IFN- did not appear to significantly
impact virus replication in the eye. This may be due to
feedback inhibition of IFN- production by mice infected
by the IFN- producing virus. Alternatively, the amount of
IFN- present in the eye following wild-type infection
may be sufficient to produce maximal antiviral effects
and the addition of more IFN- may therefore have no
obvious affect.
In this study HSV-IFN- was less virulent than the
parental viruses or marker-rescued virus following ocu-
lar or IP infection of BALB/c mice. This is consistent with
previously published results showing that transgenic
mice overexpressing IFN- are completely protected
from intraocular HSV-1 infection (Geiger et al., 1994b). In
HSV-IFN-, the IFN- gene, including its poly(A) attach-
ment signal sequence is inserted into both copies of LAT
in place of LAT nucleotides 76 to 1667. Since poly(A)
signals do not terminate RNA transcription with 100%
efficiency, it is formally possible that transcription of
downstream LAT sequences, in the absence of LAT tran-
scription from nucleotide 76 to 1667, might contribute to
the reduced virulence or pathogenicity of HSV-IFN-.
However, based on our findings with the LAT mutant
dLAT1.5, we believe this is extremely unlikely (Perng et
al., 2001). Like HSV-IFN-, both copies of LAT in dLAT1.5
contain the LAT promoter and are deleted for LAT nucle-
otides 76 to 1667. The LAT regions in these two mutants
are therefore identical, except that HSV-IFN- contains
the IFN- gene inserted into the deleted region of LAT.
However, in contrast to HSV-IFN-, dLAT1.5 has in-
creased virulence in mice. Thus, in the absence of LAT
nucleotides 76 to 1667, expression of LAT downstream of
TABLE 1
Survival of BALB/c Mice Following Ocular Challenge with HSV-IFN-a
Virus
4  107
ip
4  106 4  105 4  104 4  103 4  102 LD50
Ocular ip Ocular ip Ocular ip Ocular ip Ocular ip Ocular ip
HSV-IFN- 1/5 0/5 2/5 0/25 2/5 2/5 4/5 4/5 5/5 5/5 5/5 5 103 1.6 105
dLAT2903 0/5 0/5 0/5 0/25 1/5 0/5 3/5 1/5 4/5 5/5 5/5 3 102 1.3 104
HSV-IFN-R ND ND ND 0/10 0/5 0/5 2/5 2/5 4/5 5/5 5/5 6 102 4 103
McKrae ND 0/5 ND 0/25 ND 0/5 ND 0/5 ND 5/5 ND 4 102 ND
a BALB/c mice were challenged ocularly or ip with the specified amount of virus and survival was determined 28 and 14 days after challenge,
respectively.
b LD50 was determined by the Reed and Muench method (Burleson et al., 1992).
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nucleotide 1667 increased virulence in dLAT1.5. Potential
read through of LAT sequences downstream from 1667
in HSV-IFN- would therefore be expected to increase,
rather than decrease, virulence in mice. Thus, the IFN-
expressed by HSV-IFN- may have reduced virulence
even more than the comparison to wild-type virus sug-
gested.
Compared to the parental viruses, infection with HSV-
IFN- resulted in earlier appearance of virus in the TG
and brains of infected mice. This is consistent with a
previous report in which HSV-1-infection of IFN-R/
mice, which have increased levels of circulating IFN-
(Matthys et al., 1998), resulted in increased virus titers in
FIG. 5. Cytokine production by splenocytes after infection with HSV-
IFN-. BALB/c mice were ocularly infected with 2  105 PFU per eye of
HSV-IFN-, McKrae, or dLAT2903 as described under Materials and Meth-
ods. Mice were euthanized on the indicated days. Spleens from two mice
per group were harvested, and single cell suspensions of splenocytes
were prepared and stimulated in vitro for 72 h with UV-inactivated McKrae,
as described under Materials and Methods. The concentrations of IL-2,
IL-4, and IFN- in the supernatants were measured by ELISA. Each point
represents the mean of the titers from 6 samples. (A) IL-2 production; (B)
IL-4 production; and (C) IFN- production.
FIG. 6. CTL and lymphocyte proliferation activities in spleens of mice
infected with HSV-IFN-. BALB/c mice were ocularly infected with 2 
105 PFU per eye of HSV-IFN-, McKrae, or dLAT2903, as described
under Materials and Methods. Spleens cells were collected on the
days indicated and single cell suspensions of splenocytes were pre-
pared. (A) CTL activity. Splenocytes from each group were treated with
anti-CD4 mAb. 51Cr release assays were done with splenocytes as
effector cells and HSV-1-infected CL7 cells as target cells as described
under Materials and Methods. Each point represents mean  SEM for
eight replicates from 2 mice. Spontaneous release was 30% of total
release. The data for E:T 20:1 are shown. The CTL activity for E:T 10:1
at Day 3 was 23  4, 18  5, 21  3, and 4  2 for HSV-IFN-,
dLAT2903, McKrae, and mock-infected mice, respectively, while for E:T
5:1 it was 9  2, 10  3, 9  2, and 3  2 for HSV-IFN-, dLAT2903,
McKrae, and mock-infected mice, respectively. (B) Lymphocyte prolif-
eration. Splenocytes were primed in vitro for 72 h and cells were
labeled with [3H]thymidine for 24 h as described under Materials and
Methods. Each point represents mean  SEM for eight replicates from
2 mice.
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their TGs compared to wild-type control mice (Cantin et
al., 1995). These results suggest that increased circulat-
ing IFN- may result in earlier detection of HSV-1 in the
TG and/or increased HSV-1 titers in the TG by down
regulating other cytokine such as IL-10. IL-10 is a TH2
cytokine that has been detected in TG of HSV-1-infected
mice (Halford et al., 1996) and its activity can be reduced
by increased concentrations of IFN- (El-Sherif et al.,
2001).
Interestingly, the earlier appearance of HSV-IFN- in
the TGs and brain did not result in more death in infected
mice. In fact, mice infected with HSV-IFN- virus showed
less neurovirulence and started dying approximately 2
days later than mice infected with parental viruses. The
decreased neurovirulence of HSV-IFN- parallels the de-
creased neurovirulence reported for vaccinia virus ex-
pressing IFN- (Ramsay et al., 1993; Ramshaw et al.,
1997). However, in contrast to HSV-IFN-, with vaccinia
virus, IFN- protection also decreased viral replication.
IFN- regulates TH1 and TH2 responses, both in vitro
(Gajewski et al., 1988, 1989) and in vivo (Belosevic et al.,
1989; Scott, 1991), by inhibiting the proliferative response
of TH2 cells. Consistent with this, we showed here that
splenocytes from HSV-IFN--infected mice produced a
strong TH1 response and no TH2 response. CD8
 T cells
are important producers of IFN-. IFN- appears to me-
diate pathogen clearance by contributing to the growth
and differentiation of precursor CTL (pCTL) into active
CTL following infection (Harty et al., 2000; Maraskovsky
et al., 1989; Simon et al., 1986). In this study the CTL
activity in mice declined after Day 3, with both wild-type
and HSV-IFN- viruses. In contrast, in other studies CTL
activity in mice peaked between Day 6 and Day 9 postin-
fection (Nash et al., 1980). This difference is probably due
to the more virulent nature of the wild-type virus used
here, with the weakened condition of the mice resulting
in shut down of IFN-. In fact, although in the present
study all groups of infected mice had increased numbers
of CD4 and CD8 T cells by Day 7 postinfection (not
shown), the spleens from all infected mice were smaller
than uninfected controls by Day 7 postinfection and most
of the infected mice lost weight and had neurological
involvement.
HSV-IFN-, dLAT2903, and McKrae-infected mice had
similar reductions in CTL activity and proliferation activity
over time. dLAT2903 and McKrae-infected mice also had
reduced INF production over time following stimulation
with rIFN-. In contrast, lymphocytes from HSV-IFN--
infected mice produce high levels of IFN- throughout
the entire 7-day period following stimulation by rIFN-.
This ability to continue to produce IFN- may have con-
tributed to the increased survival of HSV-IFN--infected
mice.
The failure of rIFN- to stimulate IFN- production in
lymphocytes from dLAT2903 and wild-type McKrae-in-
fected mice may be due to shutdown of host genes
(including cytokine genes). Thus, down regulation of
IFN- synthesis may be one effect of virulent HSV-1
infection on the host cell. Multiple mechanisms may
contribute to the shutdown of host protein synthesis by
HSV-1 infection such as the Mx proteins and 2–5 oli-
goadenylate synthetase (Gale and Katze, 1997; Jacobs
and Langland, 1996; Samuel, 1991; Stark et al., 1998).
These systems act to promote a cellular antiviral state,
resulting in inhibition of viral gene transcription and ex-
pression and, in certain cases, apoptosis of infected
cells (Diaz-Guerra et al., 1997).
In summary, while some studies have shown that
IFN- may play a major role in the clearance of HSV-1
from the site of infection (Bouley et al., 1995; Cantin et al.,
1999; Geiger et al., 1994a, b; Hendricks et al., 1992;
Lekstrom-Himes et al., 2000), our results suggest that
application of external IFN- did not enhance viral clear-
ance from the site of infection. However, (1) HSV-IFN-
virus was less neurovirulent than its parental or marker-
rescued virus; (2) HSV-IFN- enhanced IL-2 production
and suppressed IL-4 production; and (3) splenocytes
from mice infected with HSV-IFN- produced IFN- for a
longer period of time than splenocytes from McKrae or
dLAT2903-infected mice.
FIG. 7. IFN- production by splenocytes after stimulation by rIFN-.
BALB/c mice were ocularly infected with 2  105 PFU of each virus per
eye as above. Mice were euthanized on the indicated days. Spleens
from two mice per group were harvested, single cell suspensions of
splenocytes were prepared, and duplicate samples were stimulated in
vitro for 72 h with rIFN- and the concentration of IFN- in the super-
natants was measured by ELISA as described under Materials and
Methods. Experiments were repeated twice. Each point represents the
mean of the titers from 4 mice.
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MATERIALS AND METHODS
Virus and cells
Triple plaque purified wt McKrae and LAT dLAT2903
were previously described (Perng et al., 1994). Rabbit
skin cells were used for preparation of virus stocks,
culturing mouse tear films, and determining growth ki-
netics. RS cells were grown in Eagle’s minimal essential
media (MEM) supplemented with 5% FCS. L929 cells
were used for ELISA titers and were grown in RPMI 1640
supplemented with 10% FCS.
Mice
Female inbred BALB/c and C57BL/6J (5 to 8 weeks old)
were obtained from the Jackson Laboratory (Bar Harbor,
ME).
Construction of IFN- plasmid
The parental virus for this construct was dLAT2903, a
recombinant of HSV-1 strain McKrae in which the region
of LAT from 161 to 1667 relative to the LAT transcrip-
tion start site (an EcoRV-HpaI restriction enzyme frag-
ment) was deleted from both copies of LAT (Perng et al.,
1994). This LAT-null recombinant is, thus, missing ap-
proximately 0.2 kb of the LAT promoter and 1.6 kb of the
5 end of the primary 8.3-kb LAT transcript. To make
HSV-IFN-, the BamHl B fragment of McKrae was di-
gested with SwaI and BamHl to produce a 5.5-kb DNA
fragment to produce a 5.5-kb DNA fragment including
from 1041 to 4656 of the HSV-1 LAT (Ghiasi et al.,
2001). A PacI linker was added to the 5.5-kb fragment
and ligated into the PacI site of modified pNEB193 (New
England Biolab) lacking its internal BamHl site. The re-
sulting plasmid was digested with StyI-HpaI to remove
the 1.6-kb LAT fragment corresponding to LAT 76 to
1667 nt. A BamHl linker was added and the resulting
plasmid was designated pLAT (Ghiasi et al., 2001). pLAT
contained 880 bp upstream of the BamHl site and 2989
bp downstream of the BamHl site. A plasmid (ATCC
clone 63170) containing the murine IFN- gene was
digested with BserI. This released a 656-bp insert con-
taining the complete 155 amino acid coding region of the
IFN- gene plus 36 and 155 bp noncoding sequences in
its 5 and 3 regions, respectively. After addition of the
BamHl linker, the insert was ligated into the BamHl site
of pLAT1.6. The resulting plasmid, containing a 656-bp
IFN- insert bounded by 880- and 2989-bp LAT inserts,
was designated pLAT1.6-IFN-.
Generation of HSV-IFN-
HSV-IFN- was generated by homologous recombina-
tion as we previously described (Perng et al., 1994).
Briefly, pLAT1.6-IFN- was cotransfected with infectious
dLAT2903 DNA by the calcium phosphate method. Vi-
ruses from the cotransfection were plated, and then
isolated plaques were picked and screened for inser-
tion of the IFN- using restriction digestion and South-
ern blot analysis. Selected plaques containing the
IFN- gene were plaque-purified eight times and re-
analyzed by restriction digestion and Southern blot
analysis to ensure that the IFN- DNA was present in
the LAT region. A final plaque was purified and des-
ignated HSV-IFN-. A marker-rescued virus, HSV-IFN-
R, in which the IFN- gene was removed and the
original deletion of the LAT gene was restored, was
also constructed. HSV-IFN-R was generated by co-
transfection and homologous recombination of infec-
tious HSV-IFN- DNA with the original pLAT plasmid.
Virus replication in tissue culture
RS cell monolayers at 70–80% confluency were in-
fected with HSV-IFN- at 0.01 PFU/cell. Virus was har-
vested at various times by two cycles of freeze-thawing
the monolayers with medium. Virus titers were then de-
termined by standard plaque assays on RS cells, as we
described previously (Ghiasi et al., 1994).
Virus titration in tear film
Tear films were collected daily from the eyes of 5 mice
(10 eyes) per group from Day one through Day 9 post-
challenge using a Dacron-tipped swab (Ghiasi et al.,
1995). Each swab was placed in 0.5 ml tissue culture
medium and squeezed, and the inoculated medium was
titrated by a standard plaque assay on RS cells.
Detection of infectious virus in whole eye, TG, and
brain
Mice were euthanized at various times postinfection and
individual TGs, eyes, and brains were harvested and indi-
vidually homogenized as described previously (Ghiasi et al.,
1999). The viral titer of the resulting supernatant was mea-
sured on RS cells by standard plaque assays.
Lymphokines ELISA assay
Mice were euthanized at various times postinfection
and single cell suspensions of spleen cells were pre-
pared. Spleen cells were cultured in 24-well plates in a
humidified 5% CO2 atmosphere for 72 h at a concentra-
tion of 2  105 cells/well in a total volume of 1 ml.
Lymphocytes were cultured with medium alone, medium
containing 5 g of recombinant murine IFN- (rIFN-)
(Peprotech Corp), or medium containing 5 PFU/cell of
UV-inactivated McKrae virus. The supernatants were col-
lected after 72 h of culture and stored at 70°C until
their use in an ELISA assay. Cell-free culture superna-
tants were assayed in triplicate for IL-2, IL-4, and IFN-
using specific ELISA assays (BD PharMingen, San Di-
ego, CA). The concentration of each cytokine in the
supernatants was estimated by comparing the optical
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densities of the unknowns to those of the standards and
is presented as mean picogram per milliliter  standard
error.
Lymphocyte proliferation response
Spleens from challenged mice were removed, and
single cell suspensions were prepared and stimulated in
vitro with 5 PFU/cell of UV-inactivated McKrae for 72 h.
On Day 3, 1 Ci of [3H]thymidine was added to 2  105
lymphocytes. Incorporation of [3H]thymidine was deter-
mined 24 h later, as previously described (Ghiasi et al.,
1994). Controls included unstimulated lymphocytes from
challenged mice and lymphocytes from naı¨ve mice.
CTL assay
Spleens from infected mice were removed aseptically
and single cell suspensions were prepared as described
previously (Ghiasi et al., 1994). Prior to CTL assays,
effector cells were depleted of CD4 T cells using L3T4
mAb plus low-tox M rabbit complement (Cedarlane) for
30 min as described previously (Ahmed et al., 1987). The
CL7 target cells were infected with HSV-1 (McKrae) at a
multiplicity of infection (m.o.i.) of 10 PFU/cell for 3 h and
labeled for 45 min with 51Cr as we described previously
(Ghiasi et al., 1994). After labeling, the target cells were
washed, and 2  104 target cells were incubated with
different ratios of effector to target cells (20:1, 10:1, and
5:1) for 4 h at 37°C. The amount of specific 51Cr released
was calculated as previously described (Ahmed et al.,
1987).
Statistical analysis
The Student t test and Fisher’s exact test were per-
formed using Instat (GraphPad, San Diego, CA), to ana-
lyze protective parameters. Results were considered to
be statistically significant when the P value was less
than 0.05.
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